One World One Health｜食・医療・環境の安全・安心

FY2022:

1. Research on virus stabilizing agents in collaboration with Nitta Gelatin and Dairy Farming University was published. This basic research will contribute to the stabilization of virus-based therapeutics.
   Kadji FMN, Kotani K, Tsukamoto H, Hiraoka Y, Hagiwara K.
   Stability of enveloped and nonenveloped viruses in hydrolyzed gelatin liquid formulations.
   Virol J. 2022 May 27;19(1):94. doi: 10.1186/s12985-022-01819-w.


2. Dr. Hagiwara research group of Rakuno Gakuen University reported that asthma and allergy were alleviated by administration of functional lactic acid bacteria in a mouse model.
   Kishida S, Kato-Mori Y, Okamoto M, Hagiwara K. Anti-inflammatory effect of a
   specific Lactiplantibacillus plantarum in an ovalbumin-induced asthma model.
   Microbiol Immunol. 2022 Sep;66(9):442-452. doi: 10.1111/1348-0421.13014.

FY2023:

1. Dr. Hagiwara research group of Rakuno Gakuen University in collaboration with Dr. Boldbaatar of Mongolian University of Life Sciences discovered hepatitis E infection in Mongolian small ruminants and published in an international journal.
   Batmagnai E, Boldbaatar B, Sodbayasgalan A, Kato-Mori Y, Hagiwara K.
   Hepatitis E Virus (HEV) Spreads from Pigs and Sheep in Mongolia.
   (Basel). 2023 Mar 1;13(5):891. doi: 10.3390/ani13050891.


2. A joint study between the Dr. Hagiwara research group at Rakuno Gakuen University and Professor Nakaya at Kyoto Prefectural University of Medicine confirmed the efficacy of melanoma treatment using recombinant viruses in a novel cancer treatment study, published in Medical Oncology.
   Numpadit S, Ito C, Nakaya T, Hagiwara K. Investigation of the oncolytic effect of
   Numpadit S, Ito C, Nakaya T, Hagiwara K. Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma.
   Oncol. 2023 Apr 6;40(5):138. doi: 10.1007/s12032-023-02002-z.

---

---